Analyst Ratings January 28, 2026

Morgan Stanley Lifts RTX Target to $235 Citing Growth, Margins and Re-rating Potential

Analyst optimism builds amid strong quarterly results, rising price targets from peers and a notable contract win for Raytheon unit

By Leila Farooq RTX
Morgan Stanley Lifts RTX Target to $235 Citing Growth, Margins and Re-rating Potential
RTX

Morgan Stanley increased its price target on RTX Corp. to $235 from $215 and kept an Overweight rating, pointing to the company’s positioning for continued revenue expansion, margin improvement and potential re-rating by the market. The upgrade follows a robust fourth-quarter performance and a string of price-target adjustments by other brokers, although valuation metrics show the stock trades at a high P/E relative to its Fair Value estimate.

Key Points

  • Morgan Stanley raised its RTX price target to $235 from $215 and maintained an Overweight rating, reinstating the stock as its Top Pick in Aerospace.
  • RTX reported strong fourth-quarter results with adjusted EPS of $1.55 and $24.2 billion in sales, reflecting 14% organic year-over-year growth; the stock has returned 59.74% over the past year.
  • Several peers updated targets upward - RBC Capital to $230, Vertical Research Partners to $227, TD Cowen to $225, and UBS to $208 - with UBS noting stronger-than-expected free cash flow projections for 2025 and 2026.

Morgan Stanley has raised its 12-month price objective on RTX Corp. to $235.00 from $215.00 while maintaining an Overweight rating on the aerospace and defense manufacturer. The firm cited RTX’s positioning to sustain growth, expand margins and achieve a potential re-rating as core reasons for the target lift. RTX shares were changing hands at $201.28, roughly 0.99% below their 52-week high of $203.03.


Analyst rationale and valuation

The bank highlighted what it called a "compelling valuation argument" and an "underappreciated growth story," noting that RTX currently trades at a discount to peers in the sector when viewed from certain valuation angles. At the same time, InvestingPro data shows RTX carries a price-to-earnings ratio of 39.14 and appears overvalued versus its Fair Value estimate, creating a tension between the upside case suggested by Morgan Stanley and traditional valuation metrics.

Morgan Stanley also reinstated RTX as its Top Pick within the Aerospace industry, signaling that the firm regards RTX more favorably than other names in the sector based on its current assessment.


Recent operating results and market response

RTX reported strong fourth-quarter performance, with adjusted earnings per share of $1.55 and total sales of $24.2 billion, equivalent to 14% organic growth year-over-year. The company's share-price performance has been notable as well, with a price return of 59.74% over the past year and revenue growth of 9.74% reported in the period cited by analysts.

Those results prompted several firms to revisit their models and adjust targets. RBC Capital lifted its price target to $230 while retaining an Outperform rating. Vertical Research Partners raised its target to $227 and maintained a Buy rating. TD Cowen moved its target to $225, and UBS increased its target to $208, specifically calling out strong demand, margin progress across RTX’s businesses and free cash flow projections for 2025 and 2026 that beat expectations.


Company structure and contract activity

RTX, formed by the combination of Raytheon Company and United Technologies, operates across commercial aerospace and defense through business units including Collins Aerospace, Pratt & Whitney, and Raytheon. In a separate development tied to RTX’s defense activities, Raytheon secured a $193.7 million contract modification for tube-launched optically tracked wireless guided missiles, with work scheduled to be completed by 2028.


Market cap and industry standing

InvestingPro identifies RTX as a prominent player in the Aerospace & Defense industry and places its market capitalization at nearly $270 billion. The combination of recent earnings strength, elevated analyst price targets and industry positioning underpins the optimism from Morgan Stanley and other firms, even as valuation comparisons to Fair Value suggest a more complex picture for investors weighing entry points.

Takeaway

Morgan Stanley’s move to raise its price target and reinstall RTX as a Top Pick reflects confidence in the company’s trajectory on growth and margins, supported by solid quarterly results and a notable contract award. Investors should weigh that optimism against valuation metrics that, according to InvestingPro data, indicate the stock trades at a relatively high P/E and may be overvalued relative to its Fair Value estimate.

Risks

  • Valuation tension - InvestingPro data shows RTX trading at a P/E of 39.14 and appearing overvalued relative to its Fair Value estimate, which could limit upside - this impacts equity investors and the broader market sector.
  • Execution risk - Continued margin expansion and revenue growth are central to analyst optimism; failure to sustain operational momentum would affect aerospace and defense financial performance.
  • Concentration risk in sector outlook - Changes in defense contracting or commercial aerospace demand could affect RTX’s business units such as Collins Aerospace, Pratt & Whitney and Raytheon, with implications for industry suppliers and investors.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026